Global Tissue Diagnostics
Global Tissue Diagnostics

Tissue Diagnostics Comprehensive Study by Type (Consumables(Antibodies Kits, Reagents, Probes), Instruments (Slide Staining System, Scanner)), Application (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), Other Diseases), Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, Special Staining), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Research Laboratories) Players and Region - Global Market Outlook to 2026

Tissue Diagnostics Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 200 Pages 181 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Tissue Diagnostics Market?

Tissue diagnostic performs a crucial part in the diagnosis, monitoring and supervision of cancer disease. Tissue diagnostics is also applied for the diagnosis of next-generation sequencing, decoding cancer molecular profiles and circulating tumour cells. It is done by fine-needle aspiration cytology, open biopsy and core biopsy. The extent to which cancer has penetrated the healthy tissue, stage and type of cancer can be determined with the help of biopsy. This diagnostic is used in pharmaceutical companies, contract research organizations, research laboratories and hospitals for the diagnosis of cancer. Some of the major tissue diagnostic tests are immunohistocheistry (IHC), hexatoxylin & eosin (H&E) and others.

The market study is being classified by Type (Consumables(Antibodies Kits, Reagents, Probes) and Instruments (Slide Staining System, Scanner)), by Application (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Diseases) and major geographies with country level break-up.

Roche (Switzerland), Danaher (United States), Thermo Fisher Scientific (United States), Abbott (United States), Agilent Technologies (United States), ABCAM (United Kingdom), Merck KGAA (Germany), BD (United States), Hologic (United States) and Qiagen (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bio Rad (United States), Biomeriux (France) and BioSB (United States),.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Tissue Diagnostics market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Tissue Diagnostics market by Type, Application and Region.

On the basis of geography, the market of Tissue Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The growing number of cancer incidence across the globe
  • Rising healthcare expenditure

Market Trend
  • Ongoing innovation and technological advancement on tissue diagnostics

Restraints
  • High cost associated with the diagnostics procedures

Opportunities
  • Growing demand for personalized medicines

Challenges
  • Sringent regulatory requirements





Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Tissue Diagnostics Providers, Government Regulatory and Research Organizations and End-Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Consumables(Antibodies Kits, Reagents, Probes)
  • Instruments (Slide Staining System, Scanner)
By Application
  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer (NSCLC)
  • Other Diseases
By Technology
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Digital Pathology and Workflow Management
  • Special Staining

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Research Laboratories

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The growing number of cancer incidence across the globe
      • 3.2.2. Rising healthcare expenditure
    • 3.3. Market Challenges
      • 3.3.1. Sringent regulatory requirements
    • 3.4. Market Trends
      • 3.4.1. Ongoing innovation and technological advancement on tissue diagnostics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Tissue Diagnostics, by Type, Application, Technology, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Tissue Diagnostics (Value)
      • 5.2.1. Global Tissue Diagnostics by: Type (Value)
        • 5.2.1.1. Consumables(Antibodies Kits, Reagents, Probes)
        • 5.2.1.2. Instruments (Slide Staining System, Scanner)
      • 5.2.2. Global Tissue Diagnostics by: Application (Value)
        • 5.2.2.1. Breast Cancer
        • 5.2.2.2. Gastric Cancer
        • 5.2.2.3. Lymphoma
        • 5.2.2.4. Prostate Cancer
        • 5.2.2.5. Non-Small Cell Lung Cancer (NSCLC)
        • 5.2.2.6. Other Diseases
      • 5.2.3. Global Tissue Diagnostics by: Technology (Value)
        • 5.2.3.1. Immunohistochemistry (IHC)
        • 5.2.3.2. In Situ Hybridization (ISH)
        • 5.2.3.3. Digital Pathology and Workflow Management
        • 5.2.3.4. Special Staining
      • 5.2.4. Global Tissue Diagnostics by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ambulatory Surgical Centers
        • 5.2.4.3. Diagnostic Centers
        • 5.2.4.4. Research Laboratories
      • 5.2.5. Global Tissue Diagnostics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Tissue Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Danaher (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Agilent Technologies (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ABCAM (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck KGAA (Germany)\
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BD (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hologic (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Qiagen (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Tissue Diagnostics Sale, by Type, Application, Technology, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Tissue Diagnostics (Value)
      • 7.2.1. Global Tissue Diagnostics by: Type (Value)
        • 7.2.1.1. Consumables(Antibodies Kits, Reagents, Probes)
        • 7.2.1.2. Instruments (Slide Staining System, Scanner)
      • 7.2.2. Global Tissue Diagnostics by: Application (Value)
        • 7.2.2.1. Breast Cancer
        • 7.2.2.2. Gastric Cancer
        • 7.2.2.3. Lymphoma
        • 7.2.2.4. Prostate Cancer
        • 7.2.2.5. Non-Small Cell Lung Cancer (NSCLC)
        • 7.2.2.6. Other Diseases
      • 7.2.3. Global Tissue Diagnostics by: Technology (Value)
        • 7.2.3.1. Immunohistochemistry (IHC)
        • 7.2.3.2. In Situ Hybridization (ISH)
        • 7.2.3.3. Digital Pathology and Workflow Management
        • 7.2.3.4. Special Staining
      • 7.2.4. Global Tissue Diagnostics by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ambulatory Surgical Centers
        • 7.2.4.3. Diagnostic Centers
        • 7.2.4.4. Research Laboratories
      • 7.2.5. Global Tissue Diagnostics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Tissue Diagnostics: by Type(USD Million)
  • Table 2. Tissue Diagnostics Consumables(Antibodies Kits, Reagents, Probes) , by Region USD Million (2015-2020)
  • Table 3. Tissue Diagnostics Instruments (Slide Staining System, Scanner) , by Region USD Million (2015-2020)
  • Table 4. Tissue Diagnostics: by Application(USD Million)
  • Table 5. Tissue Diagnostics Breast Cancer , by Region USD Million (2015-2020)
  • Table 6. Tissue Diagnostics Gastric Cancer , by Region USD Million (2015-2020)
  • Table 7. Tissue Diagnostics Lymphoma , by Region USD Million (2015-2020)
  • Table 8. Tissue Diagnostics Prostate Cancer , by Region USD Million (2015-2020)
  • Table 9. Tissue Diagnostics Non-Small Cell Lung Cancer (NSCLC) , by Region USD Million (2015-2020)
  • Table 10. Tissue Diagnostics Other Diseases , by Region USD Million (2015-2020)
  • Table 11. Tissue Diagnostics: by Technology(USD Million)
  • Table 12. Tissue Diagnostics Immunohistochemistry (IHC) , by Region USD Million (2015-2020)
  • Table 13. Tissue Diagnostics In Situ Hybridization (ISH) , by Region USD Million (2015-2020)
  • Table 14. Tissue Diagnostics Digital Pathology and Workflow Management , by Region USD Million (2015-2020)
  • Table 15. Tissue Diagnostics Special Staining , by Region USD Million (2015-2020)
  • Table 16. Tissue Diagnostics: by End User(USD Million)
  • Table 17. Tissue Diagnostics Hospitals , by Region USD Million (2015-2020)
  • Table 18. Tissue Diagnostics Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 19. Tissue Diagnostics Diagnostic Centers , by Region USD Million (2015-2020)
  • Table 20. Tissue Diagnostics Research Laboratories , by Region USD Million (2015-2020)
  • Table 21. South America Tissue Diagnostics, by Country USD Million (2015-2020)
  • Table 22. South America Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 23. South America Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 24. South America Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 25. South America Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 26. Brazil Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 27. Brazil Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 28. Brazil Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 29. Brazil Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 30. Argentina Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 31. Argentina Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 32. Argentina Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 33. Argentina Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 34. Rest of South America Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 35. Rest of South America Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 36. Rest of South America Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 37. Rest of South America Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 38. Asia Pacific Tissue Diagnostics, by Country USD Million (2015-2020)
  • Table 39. Asia Pacific Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 40. Asia Pacific Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 41. Asia Pacific Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 42. Asia Pacific Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 43. China Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 44. China Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 45. China Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 46. China Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 47. Japan Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 48. Japan Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 49. Japan Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 50. Japan Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 51. India Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 52. India Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 53. India Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 54. India Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 55. South Korea Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 56. South Korea Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 57. South Korea Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 58. South Korea Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 59. Taiwan Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 60. Taiwan Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 61. Taiwan Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 62. Taiwan Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 63. Australia Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 64. Australia Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 65. Australia Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 66. Australia Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 71. Europe Tissue Diagnostics, by Country USD Million (2015-2020)
  • Table 72. Europe Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 73. Europe Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 74. Europe Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 75. Europe Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 76. Germany Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 77. Germany Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 78. Germany Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 79. Germany Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 80. France Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 81. France Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 82. France Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 83. France Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 84. Italy Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 85. Italy Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 86. Italy Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 87. Italy Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 88. United Kingdom Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 89. United Kingdom Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 90. United Kingdom Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 91. United Kingdom Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 92. Netherlands Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 93. Netherlands Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 94. Netherlands Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 95. Netherlands Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 96. Rest of Europe Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 97. Rest of Europe Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 98. Rest of Europe Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 99. Rest of Europe Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 100. MEA Tissue Diagnostics, by Country USD Million (2015-2020)
  • Table 101. MEA Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 102. MEA Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 103. MEA Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 104. MEA Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 105. Middle East Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 106. Middle East Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 107. Middle East Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 108. Middle East Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 109. Africa Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 110. Africa Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 111. Africa Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 112. Africa Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 113. North America Tissue Diagnostics, by Country USD Million (2015-2020)
  • Table 114. North America Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 115. North America Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 116. North America Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 117. North America Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 118. United States Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 119. United States Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 120. United States Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 121. United States Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 122. Canada Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 123. Canada Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 124. Canada Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 125. Canada Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 126. Mexico Tissue Diagnostics, by Type USD Million (2015-2020)
  • Table 127. Mexico Tissue Diagnostics, by Application USD Million (2015-2020)
  • Table 128. Mexico Tissue Diagnostics, by Technology USD Million (2015-2020)
  • Table 129. Mexico Tissue Diagnostics, by End User USD Million (2015-2020)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Tissue Diagnostics: by Type(USD Million)
  • Table 141. Tissue Diagnostics Consumables(Antibodies Kits, Reagents, Probes) , by Region USD Million (2021-2026)
  • Table 142. Tissue Diagnostics Instruments (Slide Staining System, Scanner) , by Region USD Million (2021-2026)
  • Table 143. Tissue Diagnostics: by Application(USD Million)
  • Table 144. Tissue Diagnostics Breast Cancer , by Region USD Million (2021-2026)
  • Table 145. Tissue Diagnostics Gastric Cancer , by Region USD Million (2021-2026)
  • Table 146. Tissue Diagnostics Lymphoma , by Region USD Million (2021-2026)
  • Table 147. Tissue Diagnostics Prostate Cancer , by Region USD Million (2021-2026)
  • Table 148. Tissue Diagnostics Non-Small Cell Lung Cancer (NSCLC) , by Region USD Million (2021-2026)
  • Table 149. Tissue Diagnostics Other Diseases , by Region USD Million (2021-2026)
  • Table 150. Tissue Diagnostics: by Technology(USD Million)
  • Table 151. Tissue Diagnostics Immunohistochemistry (IHC) , by Region USD Million (2021-2026)
  • Table 152. Tissue Diagnostics In Situ Hybridization (ISH) , by Region USD Million (2021-2026)
  • Table 153. Tissue Diagnostics Digital Pathology and Workflow Management , by Region USD Million (2021-2026)
  • Table 154. Tissue Diagnostics Special Staining , by Region USD Million (2021-2026)
  • Table 155. Tissue Diagnostics: by End User(USD Million)
  • Table 156. Tissue Diagnostics Hospitals , by Region USD Million (2021-2026)
  • Table 157. Tissue Diagnostics Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 158. Tissue Diagnostics Diagnostic Centers , by Region USD Million (2021-2026)
  • Table 159. Tissue Diagnostics Research Laboratories , by Region USD Million (2021-2026)
  • Table 160. South America Tissue Diagnostics, by Country USD Million (2021-2026)
  • Table 161. South America Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 162. South America Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 163. South America Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 164. South America Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 165. Brazil Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 166. Brazil Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 167. Brazil Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 168. Brazil Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 169. Argentina Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 170. Argentina Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 171. Argentina Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 172. Argentina Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 173. Rest of South America Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 174. Rest of South America Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 175. Rest of South America Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 176. Rest of South America Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 177. Asia Pacific Tissue Diagnostics, by Country USD Million (2021-2026)
  • Table 178. Asia Pacific Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 179. Asia Pacific Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 180. Asia Pacific Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 181. Asia Pacific Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 182. China Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 183. China Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 184. China Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 185. China Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 186. Japan Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 187. Japan Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 188. Japan Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 189. Japan Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 190. India Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 191. India Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 192. India Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 193. India Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 194. South Korea Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 195. South Korea Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 196. South Korea Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 197. South Korea Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 198. Taiwan Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 199. Taiwan Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 200. Taiwan Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 201. Taiwan Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 202. Australia Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 203. Australia Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 204. Australia Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 205. Australia Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 207. Rest of Asia-Pacific Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 208. Rest of Asia-Pacific Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 209. Rest of Asia-Pacific Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 210. Europe Tissue Diagnostics, by Country USD Million (2021-2026)
  • Table 211. Europe Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 212. Europe Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 213. Europe Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 214. Europe Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 215. Germany Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 216. Germany Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 217. Germany Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 218. Germany Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 219. France Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 220. France Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 221. France Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 222. France Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 223. Italy Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 224. Italy Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 225. Italy Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 226. Italy Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 227. United Kingdom Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 228. United Kingdom Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 229. United Kingdom Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 230. United Kingdom Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 231. Netherlands Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 232. Netherlands Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 233. Netherlands Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 234. Netherlands Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 235. Rest of Europe Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 236. Rest of Europe Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 237. Rest of Europe Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 238. Rest of Europe Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 239. MEA Tissue Diagnostics, by Country USD Million (2021-2026)
  • Table 240. MEA Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 241. MEA Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 242. MEA Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 243. MEA Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 244. Middle East Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 245. Middle East Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 246. Middle East Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 247. Middle East Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 248. Africa Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 249. Africa Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 250. Africa Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 251. Africa Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 252. North America Tissue Diagnostics, by Country USD Million (2021-2026)
  • Table 253. North America Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 254. North America Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 255. North America Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 256. North America Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 257. United States Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 258. United States Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 259. United States Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 260. United States Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 261. Canada Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 262. Canada Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 263. Canada Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 264. Canada Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 265. Mexico Tissue Diagnostics, by Type USD Million (2021-2026)
  • Table 266. Mexico Tissue Diagnostics, by Application USD Million (2021-2026)
  • Table 267. Mexico Tissue Diagnostics, by Technology USD Million (2021-2026)
  • Table 268. Mexico Tissue Diagnostics, by End User USD Million (2021-2026)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Tissue Diagnostics: by Type USD Million (2015-2020)
  • Figure 5. Global Tissue Diagnostics: by Application USD Million (2015-2020)
  • Figure 6. Global Tissue Diagnostics: by Technology USD Million (2015-2020)
  • Figure 7. Global Tissue Diagnostics: by End User USD Million (2015-2020)
  • Figure 8. South America Tissue Diagnostics Share (%), by Country
  • Figure 9. Asia Pacific Tissue Diagnostics Share (%), by Country
  • Figure 10. Europe Tissue Diagnostics Share (%), by Country
  • Figure 11. MEA Tissue Diagnostics Share (%), by Country
  • Figure 12. North America Tissue Diagnostics Share (%), by Country
  • Figure 13. Global Tissue Diagnostics share by Players 2020 (%)
  • Figure 14. Global Tissue Diagnostics share by Players (Top 3) 2020(%)
  • Figure 15. Global Tissue Diagnostics share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Roche (Switzerland) Revenue: by Geography 2020
  • Figure 19. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 20. Danaher (United States) Revenue: by Geography 2020
  • Figure 21. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 22. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 23. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott (United States) Revenue: by Geography 2020
  • Figure 25. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 26. Agilent Technologies (United States) Revenue: by Geography 2020
  • Figure 27. ABCAM (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. ABCAM (United Kingdom) Revenue: by Geography 2020
  • Figure 29. Merck KGAA (Germany)\ Revenue, Net Income and Gross profit
  • Figure 30. Merck KGAA (Germany)\ Revenue: by Geography 2020
  • Figure 31. BD (United States) Revenue, Net Income and Gross profit
  • Figure 32. BD (United States) Revenue: by Geography 2020
  • Figure 33. Hologic (United States) Revenue, Net Income and Gross profit
  • Figure 34. Hologic (United States) Revenue: by Geography 2020
  • Figure 35. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Qiagen (Germany) Revenue: by Geography 2020
  • Figure 37. Global Tissue Diagnostics: by Type USD Million (2021-2026)
  • Figure 38. Global Tissue Diagnostics: by Application USD Million (2021-2026)
  • Figure 39. Global Tissue Diagnostics: by Technology USD Million (2021-2026)
  • Figure 40. Global Tissue Diagnostics: by End User USD Million (2021-2026)
  • Figure 41. South America Tissue Diagnostics Share (%), by Country
  • Figure 42. Asia Pacific Tissue Diagnostics Share (%), by Country
  • Figure 43. Europe Tissue Diagnostics Share (%), by Country
  • Figure 44. MEA Tissue Diagnostics Share (%), by Country
  • Figure 45. North America Tissue Diagnostics Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Roche (Switzerland)
  • Danaher (United States)
  • Thermo Fisher Scientific (United States)
  • Abbott (United States)
  • Agilent Technologies (United States)
  • ABCAM (United Kingdom)
  • Merck KGAA (Germany)\
  • BD (United States)
  • Hologic (United States)
  • Qiagen (Germany)
Additional players considered in the study are as follows:
Bio Rad (United States) , Biomeriux (France) , BioSB (United States),
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation